Phase I study of vaccine therapy with a cocktail of peptides for pediatric patients with refractory solid tumors

被引:1
|
作者
Akazawa, Yu
Hosono, Ako
Yoshikawa, Toshiaki
Kaneda, Hide
Hara, Junichi
Kinoshita, Yoshiaki
Kohashi, Kenichi
Manabe, Atsushi
Shioda, Yoko
Shoda, Kayoko
Shimomura, Manami
Mizuno, Shoichi
Nakamoto, Yasunari
Nakatsura, Tetsuya
机构
[1] Natl Canc Ctr, Kashiwa, Chiba, Japan
[2] Natl Canc Ctr, Tokyo, Japan
[3] Osaka City Gen Hosp, Osaka, Japan
[4] Kyushu Univ Hosp, Fukuoka, Japan
[5] St Lukes Int Hosp, Tokyo, Japan
[6] Natl Ctr Child Hlth & Dev, Tokyo, Japan
[7] Univ Fukui, Fukui, Japan
关键词
D O I
10.1158/2326-6074.CRICIMTEATIAACR18-A001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A001
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Phase I trial of temozolomide and protracted irinotecan in pediatric patients with refractory solid tumors
    Wagner, LM
    Crews, KR
    Iacono, LC
    Houghton, PJ
    Fuller, CE
    McCarville, MB
    Goldsby, RE
    Albritton, K
    Stewart, CF
    Santana, VM
    CLINICAL CANCER RESEARCH, 2004, 10 (03) : 840 - 848
  • [32] Phase 1 Study of Oxaliplatin and Irinotecan in Pediatric Patients With Refractory Solid Tumors
    McGregor, Lisa M.
    Spunt, Sheri L.
    Furman, Wayne L.
    Stewart, Clinton F.
    Schaiquevich, Paula
    Krailo, Mark D.
    Speights, RoseAnne
    Ivy, Percy
    Adamson, Peter C.
    Blaney, Susan M.
    CANCER, 2009, 115 (08) : 1765 - 1775
  • [33] PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF BISANTRENE IN REFRACTORY PEDIATRIC SOLID TUMORS
    PRATT, CB
    SINKULE, JA
    ETCUBANAS, E
    DOUGLASS, EC
    CROM, DB
    CHOI, K
    AVERY, L
    INVESTIGATIONAL NEW DRUGS, 1986, 4 (02) : 149 - 153
  • [34] A phase I study of bortezomib, etoposide and carboplatin in patients with advanced solid tumors refractory to standard therapy
    Lieu, Christopher
    Chow, Laura
    Pierson, A. Scott
    Eckhardt, S. Gail
    O'Bryant, Cindy L.
    Morrow, Mark
    Tran, Zung Vu
    Wright, John J.
    Gore, Lia
    INVESTIGATIONAL NEW DRUGS, 2009, 27 (01) : 53 - 62
  • [35] A phase I study of bortezomib, etoposide and carboplatin in patients with advanced solid tumors refractory to standard therapy
    Christopher Lieu
    Laura Chow
    A. Scott Pierson
    S. Gail Eckhardt
    Cindy L. O’Bryant
    Mark Morrow
    Zung Vu Tran
    John J. Wright
    Lia Gore
    Investigational New Drugs, 2009, 27 : 53 - 62
  • [36] Phase I study of irinotecan in pediatric patients with malignant solid tumors
    Mugishima, H
    Matsunaga, T
    Yagi, K
    Asami, K
    Mimaya, J
    Suita, S
    Kishimoto, T
    Sawada, T
    Tsuchida, Y
    Kaneko, M
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2002, 24 (02) : 94 - 100
  • [37] Phase I and Pharmacokinetic Study of Sunitinib in Pediatric Patients with Refractory Solid Tumors: A Children's Oncology Group Study
    DuBois, Steven G.
    Shusterman, Suzanne
    Ingle, Ashish M.
    Ahern, Charlotte H.
    Reid, Joel M.
    Wu, Bing
    Baruchel, Sylvain
    Glade-Bender, Julia
    Ivy, Percy
    Grier, Holcombe E.
    Adamson, Peter C.
    Blaney, Susan M.
    CLINICAL CANCER RESEARCH, 2011, 17 (15) : 5113 - 5122
  • [38] Phase I study of depsipeptide in pediatric patients with refractory solid tumors: A children's oncology group report
    Fouladi, Maryam
    Furman, Wayne L.
    Chin, Thomas
    Freeman, Burgess B., III
    Dudkin, Lorina
    Stewart, Clinton F.
    Krailo, Mark D.
    Speights, Roseanne
    Ingle, Ashish M.
    Houghton, Peter J.
    Wright, John
    Adamson, Peter C.
    Blaney, Susan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (22) : 3678 - 3685
  • [39] A Phase I Study of Histone Deacetylase Inhibitor, SB939, in Pediatric Patients with Refractory Solid Tumors
    Zorzi, A. P.
    Bernstein, M.
    Samson, Y.
    Wall, D. A.
    Desai, S.
    Weinman, N.
    Eisenhauer, E.
    Baruchel, S.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 105 - 105
  • [40] Phase I study of regorafenib in combination with vincristine and irinotecan in pediatric patients with recurrent or refractory solid tumors.
    Casanova, Michela
    Bautista, Francisco
    Hewson, Quentin Campbell
    Makin, Guy
    Marshall, Lynley V.
    Verschuur, Arnauld
    Canete, Adela
    Corradini, Nadege
    Ploeger, Bart
    Mueller, Udo
    Zebger-Gong, Hong
    Chung, John Woojune
    Geoerger, Birgit
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)